Page last updated: 2024-11-12
isolongifolol
Description
isolongifolol: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
Synonyms (7)
| Synonym |
|---|
| CHEMBL388140 , |
| isolongifolol |
| ((1s,3ar,4s,8ar,9s)-4,8,8-trimethyl-decahydro-1,4-methano-azulen-9-yl)-methanol |
| bdbm50211775 |
| [(1r,2s,7s,8s,9s)-3,3,7-trimethyl-8-tricyclo[5.4.0.02,9]undecanyl]methanol |
| [(1r,2s,7s,8r,9r)-3,3,7-trimethyl-8-tricyclo[5.4.0.02,9]undecanyl]methanol |
| 1,4-methanoazulene-9-methanol, decahydro-4,8,8-trimethyl-, (1s,3ar,4s,8as,9s)- |
Protein Targets (1)
Inhibition Measurements
Biological Processes (5)
Molecular Functions (2)
Ceullar Components (2)
Bioassays (5)
| Assay ID | Title | Year | Journal | Article |
|---|
| AID288410 | Inhibition of human UGT2B7 assessed as reduction of estriol glucuronidation at 1 uM | 2007 | Journal of medicinal chemistry, May-31, Volume: 50, Issue:11
| Isoform-selective inhibition of the human UDP-glucuronosyltransferase 2B7 by isolongifolol derivatives. |
| AID288408 | Inhibition of human UGT2B7 assessed as reduction of estriol glucuronidation at 100 uM | 2007 | Journal of medicinal chemistry, May-31, Volume: 50, Issue:11
| Isoform-selective inhibition of the human UDP-glucuronosyltransferase 2B7 by isolongifolol derivatives. |
| AID288409 | Inhibition of human UGT2B7 assessed as reduction of estriol glucuronidation at 10 uM | 2007 | Journal of medicinal chemistry, May-31, Volume: 50, Issue:11
| Isoform-selective inhibition of the human UDP-glucuronosyltransferase 2B7 by isolongifolol derivatives. |
| AID288412 | Inhibition of human UGT2B7 assessed as reduction of estriol glucuronidation | 2007 | Journal of medicinal chemistry, May-31, Volume: 50, Issue:11
| Isoform-selective inhibition of the human UDP-glucuronosyltransferase 2B7 by isolongifolol derivatives. |
| AID288411 | Inhibition of human UGT2B7 assessed as reduction of estriol glucuronidation at 0.1 uM | 2007 | Journal of medicinal chemistry, May-31, Volume: 50, Issue:11
| Isoform-selective inhibition of the human UDP-glucuronosyltransferase 2B7 by isolongifolol derivatives. |
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Research
Studies (5)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 21.80
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| Metric | This Compound (vs All) |
|---|
| Research Demand Index | 21.80 (24.57) | | Research Supply Index | 1.79 (2.92) | | Research Growth Index | 4.30 (4.65) | | Search Engine Demand Index | 18.60 (26.88) | | Search Engine Supply Index | 2.00 (0.95) |
| |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 5 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |